Global Adalimumab Biosimilar Market Analysis By Product (Exemptia, Adalirel, Cipleumab, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Dec 2023
- Report ID: 36720
- Number of Pages: 274
- Format:
-
-
-
- Alfred E. Tiefenbacher
- Amgen Inc.
- Boehringer Ingelheim International GmbH
- Glenmark
- Zydus Group
- Torrent Pharmaceuticals Ltd.
- Emcure Pharmaceuticals Ltd
- AET BioTech
- Coherus Biosciences
- Fujifilm Kyowa Kirin Biologics Co. Ltd.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible